News

PurePep EasyClean Services Set to Accelerate Development and Manufacturing of Peptide-based Drugs

March 22, 2023

The services are based on the company’s PurePrep EasyClean (PEC) orthogonal peptide purification technology.

Lynparza Approved in UK as Combination Therapy for Treatment of Metastatic Castration-Resistant Prostate Cancer

March 22, 2023

The decision was based on results from the PROpel Phase III trial.

European Commission Approves Dupixent as First, Only Targeted Medicine for Children with Severe Atopic Dermatitis

March 22, 2023

This approval makes the drug the first and only targeted medicine indicated to treat this population of children in Europe and the United States.

Sanofi Drops Lantus US List Price by 78%, Capping Out-of-Pocket Costs at $35

March 21, 2023

Sanofi intends to cut its US list price for Lantus (insulin glargine injection) by 78% and cap out-of-pocket costs at $35 for all patients with commercial insurance.

BioNTech and OncoC4 to Co-Develop mAb for Solid Tumor Indications

March 21, 2023

BioNTech will receive an exclusive worldwide license from OncoC4 to develop and commercialize its anti-CTLA-4 mAb candidate for solid tumor indications.

EMA Management Board Continues to Monitor Critical Shortages of Medicines

March 21, 2023

Additionally, the MSG discussed plans to mitigate shortages of antibiotics for the next autumn and winter season.

Sartorius and Teknova Team Up for Gene Therapy Process Development

March 21, 2023

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Samsung Biologics to Build Plant 5 as Part of Capacity Expansion to Bio Campus II

March 21, 2023

Samsung Biologics plans to invest more than ₩1.9 trillion (US$1.5 billion) in the new Incheon, South Korea, facility, which will hold a manufacturing capacity of 180,000 L.

Polyplus Introduces Novel LNP Formulation for Use in mRNA Therapeutics

March 17, 2023

Polyplus’ LipidBrick is designed to expand the scope of lipid nanoparticle formulation usage in mRNA therapeutics and vaccine development.

Stevanato Group and Recipharm to Collaborate on Pre-fillable Syringes for Soft Mist Inhaler

March 17, 2023

Stevanato Group will support development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.